Sponsored Links

BRIEF-Actelion gets Japanese nod for epoprostenol "ACT"

Related Topics

ZURICH | Mon Feb 18, 2013 11:38am EST

ZURICH Feb 18 (Reuters) - Actelion Ltd : * Actelion Pharmaceuticals Ltd : Actelion obtains marketing approval for

epoprostenol "ACT" in Japan

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.